Generic Drug Settlement Prompts More FTC Scrutiny
The Federal Trade Commission asked Cephalon Inc. Wednesday for more information about Cephalon's patent infringement suit settlements relating to the narcolepsy drug Provigil....To view the full article, register now.
Already a subscriber? Click here to view full article